Henry Gosebruch

President and CEO

Henry Gosebruch is the President and Chief Executive Officer at Neumora Therapeutics, a clinical-stage biopharmaceutical company redefining neuroscience drug development.

Mr. Gosebruch served as executive vice president and chief strategy officer at AbbVie, a global biopharmaceutical company, from December 2015 to February 2023. As a member of AbbVie’s Executive Team, he created and led AbbVie’s Corporate Strategy Office, which comprised teams focused on corporate strategy and strategic planning, competitive strategy and insights, business development and M&A, search and evaluation, alliance management, R&D decision support/portfolio analytics and the company’s corporate strategic venture capital arm, AbbVie Ventures.

During his tenure at AbbVie, Mr. Gosebruch and his team oversaw the advancement of AbbVie’s partnered pipeline and assisted in making internal portfolio decisions. Mr. Gosebruch and his team were responsible for the completion of more than 100 business development/M&A transactions and venture capital investments. Notable transactions completed under Mr. Gosebruch’s tenure include AbbVie’s partnerships with Boehringer Ingelheim for risankizumab (Skyrizi) and Genmab for epcoritamab (Epkinly) that resulted in bringing new medicines to patients across several difficult-to-treat diseases with high unmet need. Mr. Gosebruch also played a pivotal role in AbbVie’s acquisition of Allergan. During his tenure, AbbVie’s annual revenues grew from approximately $23 billion to approximately $58 billion and AbbVie’s stock price and market capitalization tripled.    

Prior to joining AbbVie, Mr. Gosebruch was co-head of J.P. Morgan’s North American M&A Group and worked on announced M&A transactions in excess of $375 billion in total value over a 20+ year career.  

Mr. Gosebruch currently serves as a member of the board of directors of Acelyrin, Inc. where he is a member of the Audit Committee and chairs the Compensation Committee. Mr. Gosebruch received a BSE in Finance from the Wharton School at the University of Pennsylvania, and is a Certified Public Accountant in Illinois.